Eszopiclone

右佐匹克隆

Report date: 2026/05/07 20:00:36
NME

Base Information

Drug NameEszopiclone
Drug Alias NameS-Zopiclone艾佐匹隆鲁尼斯塔Eszopiclonumeszopiclona +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorAnxiety Disorders +[10] 
Global Approved IndicationsSleep Initiation and Maintenance Disorders
Approved Indications in ChinaSleep Initiation and Maintenance Disorders
Original Approved Country/TerritoryUnited States
Original Approved Date2004/12/15
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSunovion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityWoodwardFlinders University +[6] 
Inactive CompaniesUniversity Of Medicine And Dentistry Of New JerseyThe Brigham and Women's HospitalSumitomo Pharma America Inc +[4] 
Active IndicationsSleepSleep Initiation and Maintenance DisordersSleep Wake Disorders +[5] 
Inactive IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorAnxiety Disorders +[5] 

Other Information

ATC CodeN05CF04
Related LinksWikipediaDrugBankKEGG